PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
38.72%
Revenue growth 1.25-1.5x PUK's 27.93%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
380.04%
Gross profit growth above 1.5x PUK's 27.93%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2200.72%
EBIT growth above 1.5x PUK's 246.79%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
2200.72%
Operating income growth above 1.5x PUK's 27.93%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
272.22%
Net income growth under 50% of PUK's 2157.71%. Michael Burry would suspect the firm is falling well behind a key competitor.
276.92%
EPS growth under 50% of PUK's 1749.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
276.92%
Diluted EPS growth under 50% of PUK's 1749.71%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.23%
Slight or no buybacks while PUK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
292.55%
Positive 10Y revenue/share CAGR while PUK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
88.75%
Positive 5Y CAGR while PUK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
121.56%
Positive 3Y CAGR while PUK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
516.49%
Net income/share CAGR above 1.5x PUK's 202.69% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
89.69%
Below 50% of PUK's 835.13%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-23.58%
Negative 3Y CAGR while PUK is 48.42%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We cut SG&A while PUK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.